{"id":"b85f5e86-75bd-5d63-bfc6-d42a28f81c8c","stable_key":"4d8e4781-3878-5818-8d0a-7dbd6e024555:chromium-diabetes-insulin-positive","predicate":"reduces","statement":"Fasting and two-hour insulin measurements decreased in both chromium-supplemented groups in the reported study.","claim_class":"observational","status":"source_derived_draft","evidence_grade":"ungraded","direction":"negative","is_public":true,"mechanism_event_id":"0b32feb9-6f21-5218-ba36-88c85dc7418c","mechanism_event_label":"The study reported an insulin change alongside its glucose findings.","subject":{"id":"89d5d39c-2663-5e0c-8eae-562a5b25a47d","slug":"chromium-iii-picolinate","display_name":"Chromium(III) picolinate / CrPic","entity_type_key":"chemical_species"},"object":{"id":"f90ed653-5a5a-563b-ba35-eeb0501465fd","slug":"fasting-plasma-insulin","display_name":"Fasting plasma insulin concentration","entity_type_key":"cellular_process"},"evidence_count":1,"mechanism_event":{"id":"0b32feb9-6f21-5218-ba36-88c85dc7418c","stable_key":"4d8e4781-3878-5818-8d0a-7dbd6e024555:chromium-diabetes-insulin-positive-event","event_type":"observed_intervention","label":"The study reported an insulin change alongside its glucose findings.","description":"Fasting and two-hour insulin measurements decreased in both chromium-supplemented groups in the reported study.","status":"provisional","compartment":null,"participants":[{"entity":{"id":"89d5d39c-2663-5e0c-8eae-562a5b25a47d","slug":"chromium-iii-picolinate","display_name":"Chromium(III) picolinate / CrPic","entity_type_key":"chemical_species"},"role":"subject","stoichiometry":null,"state_label":"","sequence_order":0,"notes":""},{"entity":{"id":"f90ed653-5a5a-563b-ba35-eeb0501465fd","slug":"fasting-plasma-insulin","display_name":"Fasting plasma insulin concentration","entity_type_key":"cellular_process"},"role":"target","stoichiometry":null,"state_label":"","sequence_order":1,"notes":""}]},"contexts":[{"dimension":"evidence_span","value_text":"{\"source_cache\": \"artifacts/chromium-research/9356027.abstract.txt\", \"locator\": \"Exact primary indexed abstract; zero-based, end-exclusive Unicode character offsets\", \"file_sha256\": \"9c9f5146517d1c6967a6f75951c79fbb828408e96693be5df98f9fb1ec91aa69\", \"start_char\": 0, \"end_char\": 1941, \"text_sha256\": \"9c9f5146517d1c6967a6f75951c79fbb828408e96693be5df98f9fb1ec91aa69\"}","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"experimental_model","value_text":"Randomized three-arm supplementation trial; 180 adults","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"exposure","value_text":"Placebo, 200 or 1,000 µg Cr/day as picolinate for four months while usual medications continued","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"limitations","value_text":"Historical single-population trial; response does not diagnose chromium deficiency. Baseline diet, medication context and replication matter; later trials reported null effects.","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"nutrient_topic","value_text":"Chromium research collection; topical membership is not evidence of a direct dietary effect.","comparator":null,"unit":null,"notes":"","entity":{"slug":"chromium","display_name":"Chromium","entity_type_key":"nutrient_element"}},{"dimension":"organism","value_text":"Human with treated type 2 diabetes","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"plain_language","value_text":"The study reported an insulin change alongside its glucose findings.","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"primary_references","value_text":"[chromium-p9356027] Elevated intakes of supplemental chromium improve glucose and insulin variables in individuals with type 2 diabetes. (1997). https://pubmed.ncbi.nlm.nih.gov/9356027/ DOI: 10.2337/diab.46.11.1786","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"tissue_or_cell_type","value_text":"HbA1c, glucose, insulin and lipids","comparator":null,"unit":null,"notes":"","entity":null}],"evidence":[{"id":"072fb36d-0773-5edc-b765-b8592dfb2294","evidence_kind":"source_excerpt","locator":"Lines 1043-1054","start_line":1043,"end_line":1054,"excerpt":"### chromium-diabetes-insulin-positive\nFasting and two-hour insulin measurements decreased in both chromium-supplemented groups in the reported study.\nCondition category: normal\nnutrient_topic: Chromium research collection; topical membership is not evidence of a direct dietary effect.\nplain_language: The study reported an insulin change alongside its glucose findings.\norganism: Human with treated type 2 diabetes\ntissue_or_cell_type: HbA1c, glucose, insulin and lipids\nexperimental_model: Randomized three-arm supplementation trial; 180 adults\nlimitations: Historical single-population trial; response does not diagnose chromium deficiency. Baseline diet, medication context and replication matter; later trials reported null effects.\nexposure: Placebo, 200 or 1,000 µg Cr/day as picolinate for four months while usual medications continued\nevidence_span: {\"source_cache\": \"artifacts/chromium-research/9356027.abstract.txt\", \"locator\": \"Exact primary indexed abstract; zero-based, end-exclusive Unicode character offsets\", \"file_sha256\": \"9c9f5146517d1c6967a6f75951c79fbb828408e96693be5df98f9fb1ec91aa69\", \"start_char\": 0, \"end_char\": 1941, \"text_sha256\": \"9c9f5146517d1c6967a6f75951c79fbb828408e96693be5df98f9fb1ec91aa69\"}\n[chromium-p9356027] Elevated intakes of supplemental chromium improve glucose and insulin variables in individuals with type 2 diabetes. (1997). https://pubmed.ncbi.nlm.nih.gov/9356027/ DOI: 10.2337/diab.46.11.1786","model_system":"Randomized three-arm supplementation trial; 180 adults","directness":"author_interpretation","verification_status":"source_derived_draft","notes":"Exact curation-document quotation, not publisher quotation. Study references: [chromium-p9356027] Elevated intakes of supplemental chromium improve glucose and insulin variables in individuals with type 2 diabetes. (1997). https://pubmed.ncbi.nlm.nih.gov/9356027/ DOI: 10.2337/diab.46.11.1786","relationship":"supports","weight":1.0,"link_notes":"","source":{"id":"fa96342a-ca01-5425-98d9-d50e29bf0abd","stable_key":"import-4d8e4781-3878-5818-8d0a-7dbd6e024555","title":"Chromium: transport, insulin signaling, nutrient interactions and essentiality debate (2026-09-17)","document_type":"imported_text","citation_label":"AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text.","file_path":"","sha256":"6cae22f9104c6de041b25c23b0fd2884cc57707ac0c9a87c20b0e665d16de5ab","revision_id":"22893798-8329-5295-9c9d-82169032fc79","review_status":"unverified_draft","notes":""}}],"relations":[],"conflicts":[],"corrections":[],"research":null}